{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:50:56Z","timestamp":1783165856229,"version":"3.54.6"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Cancer J"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Hepatocellular carcinoma (HCC) is one of the leading cancers worldwide. Classically, HCC develops in genetically susceptible individuals who are exposed to risk factors, especially in the presence of liver cirrhosis. Significant temporal and geographic variations exist for HCC and its etiologies. Over time, the burden of HCC has shifted from the low-moderate to the high sociodemographic index regions, reflecting the transition from viral to nonviral causes. Geographically, the hepatitis viruses predominate as the causes of HCC in Asia and Africa. Although there are genetic conditions that confer increased risk for HCC, these diagnoses are rarely recognized outside North America and Europe. In this review, we evaluate the epidemiologic trends and risk factors of HCC and discuss the prevention with surveillance and short management.<\/jats:p>","DOI":"10.1097\/ppo.0000000000000684","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T11:06:11Z","timestamp":1696503971000},"page":"259-265","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Hepatocellular Carcinoma\u2014Southeast Asia Updates"],"prefix":"10.1097","volume":"29","author":[{"given":"Satender Pal","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Madke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv Kumar","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20250928","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","article-title":"Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification [published online November 28, 2020]","volume":"149","year":"2021","journal-title":"Adv Cancer Res"},{"key":"bib2-20250928","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"bib3-20250928","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s40471-019-00188-3","article-title":"The changing epidemiology of primary liver cancer","volume":"6","year":"2019","journal-title":"Curr Epidemiol Rep"},{"key":"bib4-20250928","first-page":"332","article-title":"Epidemiology of hepatocellular carcinoma in the Asia-Pacific region","volume":"10","year":"2016","journal-title":"Gut Liver"},{"key":"bib5-20250928","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3350\/cmh.2021.0171","article-title":"Hepatocellular carcinoma statistics in South Korea","volume":"27","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"bib6-20250928","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer Analysis Project","volume":"45","year":"2013","journal-title":"Nat Genet"},{"key":"bib7-20250928","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","year":"2017","journal-title":"Hepatol Int"},{"key":"bib8-20250928","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJM200211213472119","article-title":"Hepatitis B e antigen and the risk of hepatocellular carcinoma","volume":"347","year":"2002","journal-title":"N Engl J Med"},{"key":"bib9-20250928","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"bib10-20250928","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","year":"2012","journal-title":"Gastroenterology"},{"key":"bib11-20250928","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/j.gastro.2003.12.049","article-title":"Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance","volume":"126","year":"2004","journal-title":"Gastroenterology"},{"key":"bib12-20250928","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/0974-777X.52979","article-title":"Association between hepatitis C and hepatocellular carcinoma","volume":"1","year":"2009","journal-title":"J Glob Infect Dis"},{"key":"bib13-20250928","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/annonc\/mdu020","article-title":"Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies","volume":"25","year":"2014","journal-title":"Ann Oncol"},{"key":"bib14-20250928","doi-asserted-by":"crossref","first-page":"329","DOI":"10.14309\/ajg.0000000000000966","article-title":"Alcohol intake and mortality in patients with chronic viral hepatitis: a nationwide cohort study","volume":"116","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"bib15-20250928","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12929-017-0327-y","article-title":"ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective","volume":"24","year":"2017","journal-title":"J Biomed Sci"},{"key":"bib16-20250928","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"bib17-20250928","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3748\/wjg.v28.i3.310","article-title":"Non-alcoholic fatty liver disease and hepatocellular carcinoma: clinical challenges of an intriguing link","volume":"28","year":"2022","journal-title":"World J Gastroenterol"},{"key":"bib18-20250928","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s12072-023-10498-w","article-title":"Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study","volume":"17","year":"2023","journal-title":"Hepatol Int"},{"key":"bib19-20250928","doi-asserted-by":"crossref","first-page":"e0240565","DOI":"10.1371\/journal.pone.0240565","article-title":"Exploring aflatoxin contamination and household-level exposure risk in diverse Indian food systems","volume":"15","year":"2020","journal-title":"PloS One"},{"key":"bib20-20250928","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/v12101112","article-title":"HBV prevention and treatment in countries of Central Asia and the Caucasus","volume":"12","year":"2020","journal-title":"Viruses"},{"key":"bib21-20250928","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/JHC.S221187","article-title":"Hepatocellular carcinoma mechanisms associated with chronic HCV infection and the impact of direct-acting antiviral treatment","volume":"7","year":"2020","journal-title":"J Hepatocell Carcinoma"},{"key":"bib23-20250928","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.annonc.2019.12.001","article-title":"Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with intermediate and advanced\/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO","volume":"31","year":"2020","journal-title":"Ann Oncol"},{"key":"bib24-20250928","first-page":"S135","article-title":"LBA3 early detection and localization of multiple cancers using a blood-based methylation assay (ELSA- seq)","volume":"31","year":"2020","journal-title":"Ann Oncol"},{"key":"bib25-20250928","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000514174","article-title":"Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update","volume":"10","year":"2021","journal-title":"Liver Cancer"},{"key":"bib26-20250928","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ajg.2015.100","article-title":"Alpha-fetoprotein measurement benefits hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"110","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"bib27-20250928","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1038\/s41598-020-61028-9","article-title":"Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma","volume":"10","year":"2020","journal-title":"Sci Rep"},{"key":"bib28-20250928","first-page":"108","article-title":"The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis","volume":"19","year":"2020","journal-title":"EXCLI J"},{"key":"bib29-20250928","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000367775","article-title":"Survival analysis over 28 years of 173,378 patients with hepatocellular carcinoma in Japan","volume":"5","year":"2016","journal-title":"Liver Cancer"},{"key":"bib30-20250928","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.15419\/bmrat.v6i11.577","article-title":"Clinical features and survival of patients with hepatocellular carcinoma at a cancer treatment facility","volume":"6","year":"2019","journal-title":"Biomed Res Ther"},{"key":"bib31-20250928","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/hepr.13892","article-title":"Clinical practice guidelines for hepatocellular carcinoma: the Japan Society of Hepatology 2021 version (5th JSH-HCC guidelines)","volume":"53","year":"2023","journal-title":"Hepatol Res"},{"key":"bib32-20250928","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000523997","article-title":"Guidelines for diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus in China (2021 edition)","volume":"11","year":"2022","journal-title":"Liver Cancer"},{"key":"bib33-20250928","first-page":"206","article-title":"Clinical practice guidelines and real-life practice in hepatocellular carcinoma: a Chinese perspective","volume":"29","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"bib34-20250928","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1159\/000509424","article-title":"Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition)","volume":"9","year":"2020","journal-title":"Liver Cancer"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:00:11Z","timestamp":1759042811000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0000000000000684","relation":{},"ISSN":["1540-336X","1528-9117"],"issn-type":[{"value":"1540-336X","type":"electronic"},{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}